CD74-mediated signaling is often co-activated by CD44, a major ECM receptor that also serves as a main cancer stem cell marker, leading to the activation of key oncogenic pathways, including the MAPK/ERK and PI3K/Akt pathways, which promote tumor cell proliferation, migration, and survival [26]. This evidence concerns the gene CD44 and neoplasm.